Page last updated: 2024-11-05

cyclopentanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cyclopentanone is a cyclic ketone with a five-membered ring. It is a colorless liquid with a pungent odor. Cyclopentanone is an important intermediate in the synthesis of various pharmaceuticals, pesticides, and other organic compounds. It is also used as a solvent in some industrial processes. Cyclopentanone is synthesized by the oxidation of cyclopentane or by the cyclization of 1,4-dichlorobutane. The compound is known for its reactivity towards nucleophiles, which is exploited in several organic reactions. It is also used as a starting material for the preparation of various heterocycles, such as pyrrolidine and piperidine. Cyclopentanone is studied for its potential applications in organic synthesis and its contribution to the understanding of the chemistry of cyclic ketones.'

Cross-References

ID SourceID
PubMed CID8452
CHEMBL ID18620
CHEBI ID16486
MeSH IDM0050237

Synonyms (65)

Synonym
wln: l5vtj
nsc-4122
adipic ketone
ketopentamethylene
dumasin
nsc4122
ketocyclopentane
adipinketon
oxocyclopentane
CHEBI:16486 ,
einecs 204-435-9
nsc 4122
un2245
cyclopentanone [un2245] [flammable liquid]
ai3-16609
hsdb 2822
inchi=1/c5h8o/c6-5-3-1-2-4-5/h1-4h
cyclopentanone ,
120-92-3
C00557
cyclopentanone, >=99%, fg
cyclopentanone, reagentplus(r), >=99%
CHEMBL18620 ,
bdbm50028830
AKOS000118935
A804615
NCGC00248575-01
cyclopentanon
dtxsid3029154 ,
cas-120-92-3
dtxcid209154
tox21_303562
NCGC00257495-01
NCGC00257798-01
tox21_200244
cyclopentan-1-one
adipin keton
unii-220w81tn3s
220w81tn3s ,
ec 204-435-9
cyclopentanone [un2245] [flammable liquid]
BP-12623
FT-0624259
fema no. 3910
cyclopentanone [fhfi]
cyclopentanone [hsdb]
cyclopentanone [mi]
cyclopentaneon
cyclo-pentanone
STR00465
un 2245
F0001-0334
mfcd00001409
cyclopentanone, reagentplus(r), >=99.0%
cyclopentanone, analytical standard
dumasine
fema 3910
3-acetyl-6-methyl-pyran-2,4(3h)-dione
Q416065
EN300-19196
STL185563
AMY37126
cyclopentanone (2,2,5,5-d4)
2-cyclopentanone
?cyclopentanone

Research Excerpts

Overview

Cyclopentanone is a saturated monoketone typically used as an intermediate in the manufacture of pharmaceuticals, biologicals, insecticides, and rubber chemicals.

ExcerptReferenceRelevance
"Cyclopentanone is a saturated monoketone typically used as an intermediate in the manufacture of pharmaceuticals, biologicals, insecticides, and rubber chemicals. "( Field Comparison of Cyclopentanone Versus Carbon Dioxide as an Attractant for Adult Mosquitoes in Southeast Queensland, Australia.
Francis, DP; Jansen, CC; Philippe-Janon, JC; Shivas, MA; van den Hurk, AF, 2015
)
2.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Maillard reaction productAny thermal degradation product obtained as a result of a chemical reaction between an amino acid and a reducing sugar (Maillard reaction, a non-enzymatic browning procedure that usually imparts flavour to starch-based food products).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
cyclopentanonesAny alicyclic ketone that consists of a cyclopentane skeleton substituted by at least one oxo group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency2.34650.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159553
pregnane X nuclear receptorHomo sapiens (human)Potency5.52590.005428.02631,258.9301AID1346982
aryl hydrocarbon receptorHomo sapiens (human)Potency69.56730.000723.06741,258.9301AID743085
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transcription intermediary factor 1-alphaHomo sapiens (human)IC50 (µMol)0.13580.13581.837910.0000AID1619194
Phenylethanolamine N-methyltransferaseBos taurus (cattle)IC50 (µMol)1,000.00000.96005.32008.0000AID155162
E3 ubiquitin-protein ligase TRIM33Homo sapiens (human)IC50 (µMol)0.23350.23351.01654.6900AID1619193
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
transcription by RNA polymerase IITranscription intermediary factor 1-alphaHomo sapiens (human)
positive regulation of gene expressionTranscription intermediary factor 1-alphaHomo sapiens (human)
protein ubiquitinationTranscription intermediary factor 1-alphaHomo sapiens (human)
protein catabolic processTranscription intermediary factor 1-alphaHomo sapiens (human)
regulation of protein stabilityTranscription intermediary factor 1-alphaHomo sapiens (human)
regulation of apoptotic processTranscription intermediary factor 1-alphaHomo sapiens (human)
response to peptide hormoneTranscription intermediary factor 1-alphaHomo sapiens (human)
negative regulation of DNA-templated transcriptionTranscription intermediary factor 1-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionTranscription intermediary factor 1-alphaHomo sapiens (human)
epithelial cell proliferationTranscription intermediary factor 1-alphaHomo sapiens (human)
negative regulation of epithelial cell proliferationTranscription intermediary factor 1-alphaHomo sapiens (human)
calcium ion homeostasisTranscription intermediary factor 1-alphaHomo sapiens (human)
regulation of vitamin D receptor signaling pathwayTranscription intermediary factor 1-alphaHomo sapiens (human)
cellular response to estrogen stimulusTranscription intermediary factor 1-alphaHomo sapiens (human)
regulation of signal transduction by p53 class mediatorTranscription intermediary factor 1-alphaHomo sapiens (human)
methylationPhenylethanolamine N-methyltransferaseBos taurus (cattle)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseBos taurus (cattle)
negative regulation of transcription by RNA polymerase IIE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
protein ubiquitinationE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
regulation of transforming growth factor beta receptor signaling pathwayE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
negative regulation of BMP signaling pathwayE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
negative regulation of DNA-templated transcriptionE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
methylated histone bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
p53 bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
chromatin bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
transcription coactivator activityTranscription intermediary factor 1-alphaHomo sapiens (human)
protein kinase activityTranscription intermediary factor 1-alphaHomo sapiens (human)
signaling receptor bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
protein bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
zinc ion bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
nuclear receptor bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
estrogen response element bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
ubiquitin protein ligase activityTranscription intermediary factor 1-alphaHomo sapiens (human)
lysine-acetylated histone bindingTranscription intermediary factor 1-alphaHomo sapiens (human)
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseBos taurus (cattle)
DNA bindingE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
ubiquitin-protein transferase activityE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
protein bindingE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
zinc ion bindingE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
co-SMAD bindingE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
R-SMAD bindingE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
male germ cell nucleusTranscription intermediary factor 1-alphaHomo sapiens (human)
nucleusTranscription intermediary factor 1-alphaHomo sapiens (human)
nucleoplasmTranscription intermediary factor 1-alphaHomo sapiens (human)
perichromatin fibrilsTranscription intermediary factor 1-alphaHomo sapiens (human)
mitochondrionTranscription intermediary factor 1-alphaHomo sapiens (human)
cytosolTranscription intermediary factor 1-alphaHomo sapiens (human)
euchromatinTranscription intermediary factor 1-alphaHomo sapiens (human)
chromatinTranscription intermediary factor 1-alphaHomo sapiens (human)
nucleusE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
nucleoplasmE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
chromatinE3 ubiquitin-protein ligase TRIM33Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1269411Antidiabetic activity in 24 hrs serum-deprived rat glomerular mesangial cells assessed as reduction of high glucose-induced fibronectin and beta-actin expression ratio at 0.25 uM after 48 hrs by Western blot analysis relative to control2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines.
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1269410Antidiabetic activity in 24 hrs serum-deprived rat glomerular mesangial cells assessed as reduction of high glucose-induced fibronectin and beta-actin expression ratio at 5 uM after 48 hrs by Western blot analysis relative to control2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines.
AID1269408Antidiabetic activity in 24 hrs serum-deprived rat glomerular mesangial cells assessed as reduction of high glucose-induced fibronectin and beta-actin expression ratio at 0.5 uM after 48 hrs by Western blot analysis relative to control2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines.
AID227699Virtual screen for compounds with anticonvulsant activity2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
AID155162Inhibitory activity against phenylethanolamine N-methyl-transferase1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
Importance of the aromatic ring in adrenergic amines. 5. Nonaromatic analogues of phenylethanolamine as inhibitors of phenylethanolamine N-methyltransferase: role of hydrophobic and steric interactions.
AID1269409Antidiabetic activity in 24 hrs serum-deprived rat glomerular mesangial cells assessed as reduction of high glucose-induced fibronectin and beta-actin expression ratio at 1 uM after 48 hrs by Western blot analysis relative to control2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (144)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (5.56)18.7374
1990's9 (6.25)18.2507
2000's53 (36.81)29.6817
2010's61 (42.36)24.3611
2020's13 (9.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 63.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index63.91 (24.57)
Research Supply Index4.99 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index106.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (63.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (3.42%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other141 (96.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]